Rifampicin, vitamin K and osteomalacia
Chouraqui, J.P.
Archives Francaises de Pediatrie 43(4): 292
1986
ISSN/ISBN: 0003-9764 PMID: 3767591 Document Number: 272755
Document emailed within 1 workday
Related Documents
Peacock, M.; Heyburn, P.J.; Aaron, J.E. 1977: Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3 Calcified Tissue Research 22(Suppl): 55-62David, H.P.; Woloszczuk, W.; Kovarik, J. 1983: Antiepileptic-induced osteomalacia and vitamin D therapy Der Nervenarzt 54(12): 647-650
Scharla, S. 2008: Diagnosis of Disorders of Vitamin D-Metabolism and Osteomalacia Clinical Laboratory 54(11-12): 451-459
Tsugawa, N. 2018: Rickets/Osteomalacia. Determination of vitamin D metabolites Clinical Calcium 28(10): 1327-1334
Hernigou, P. 1995: Historical overview of rickets, osteomalacia, and vitamin D Revue du Rhumatisme 62(4): 261-270
Peacock, M.; Aaron, J.E.; Heyburn, P.J.; Nordin, B.E. 1977: The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia Advances in Experimental Medicine and Biology 81: 431-440
Teotia, S.P.S.; Teotia, M. 2005: If you see primary hyperparathyroidism in mothers with vitamin-D deficiency osteomalacia: think of tertiary Journal of the Association of Physicians of India 53: 11-13
Wilczek, H.; Pacovský, V.; Hazuková, L.; Kalvach, Z.; Sisková, M. 1986: Treatment of osteomalacia caused by anticonvulsants with a derivative of vitamin D (case report) Sbornik Lekarsky 88(12): 365-368
Menger, H.; Pfingsten, H.; Hintze, G.; Köbberling, J.; Jörg, J. 1993: A rare differential diagnosis of waddling gait--osteomalacia caused by vitamin D deficiency Der Nervenarzt 64(6): 407-410
Charhon, S.; Rouillat, M.; Bouvier, M.; Meunier, P.J.; Lejeune, E. 1981: Vitamin-sensitive osteomalacia in condensing bone metastases of prostatic origin. Apropos of 2 cases Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(6): 469-476
Du Bois, R. 1972: Osteomalacia in adults. I. Osteomalacia of supply. Radiological signs Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 17(2): 277-279
Chouraqui, J.P.; Bessard, G.; Favier, M.; Kolodie, L.; Rambaud, P. 1982: Haemorrhage associated with vitamin K deficiency in pregnant women and newborns. Relationship with rifampicin therapy in two cases Therapie 37(4): 447-450
Christiansen, C.; Rødbro, P. 1979: Anticonvulsant-induced osteomalacia. Vitamin D metabolism disorders in epileptics on anticonvulsant therapy Ugeskrift for Laeger 141(5): 280-284
Helliwell, P.S.; Ibrahim, G.H.; Karim, Z.; Sokoll, K.; Johnson, H. 2006: Unexplained musculoskeletal pain in people of South Asian ethnic group referred to a rheumatology clinic - relationship to biochemical osteomalacia, persistence over time and response to treatment with calcium and vitamin D Clinical and Experimental Rheumatology 24(4): 424-427
Medoff, G.; Kwan, C.N.; Schlessinger, D.; Kobayashi, G.S. 1973: Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B Cancer Research 33(6): 1146-1149
Rossolini, A.; Cellesi, C.; Debolini, A. 1973: Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination Il Farmaco; Edizione Pratica 28(6): 345-355
Poupon, R.Y.; Meyniel, D.; Petit, J.; Gustot, P.; Darnis, F. 1979: Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin Annales de Medecine Interne 130(6-7): 371-375
Saltoglu, N.; Tasova, Y.; Inal, A.S.; Seki, T.; Aksu, H.S. 2002: Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis Saudi Medical Journal 23(8): 921-924
Panchagnula, R.; Singh, I.; Kaur, K.J.; Kaul, C.L. 1999: Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations Methods and Findings in Experimental and Clinical Pharmacology 21(9): 625-628
Acocella, G.; Segre, G. 1974: Kinetics of rifampicin and desacetyl-rifampicin in plasma, bile, and urine in humans and the effect of repeated administrations Acta Pharmaceutica Suecica 11(6): 657-658